The biotechnology industry is a leader of innovation and improvement in global healthcare and agriculture and is vital to the development of new procedures for preventing, diagnosing, and treating health conditions. Biotechnology is one of the key reasons why we are living longer, safer, and healthier lives.
The global biotechnology industry is expanding rapidly, and long-term sustained growth is expected. The market is expected to surpass $700 billion by 2025, according to a new report by Grand View Research, Inc. The report describes key factors contributing to the continued market growth, such as the demand for new treatments (for example, personalised medicine), the increasing prevalence of diseases such as various cancers in aging populations, the rise in the demand for food and agricultural products owing to a growing global population (China and India in particular), and an increasingly globalised clinical trials industry.
The geographical distribution of clinical trials is moving from developed nations to emerging countries. Globalisation has increased investment in new product development in emerging countries in Central and Eastern Europe, Asia, Latin America and the Middle East as the rising costs of clinical trials and patient recruitment issues has caused biopharmaceutical companies to expand their horizons internationally.
Accuracy of language is of the greatest importance in biotechnology, particularly in research, manufacturing and clinical trials conducted in foreign markets. Clarity of the language in key documents such as contracts, patents, Informed Consent Forms (ICF), Patient Information Leaflets (PIL), health and safety protocols, drug labelling, and more, is also of vital importance in the biotechnology industry. That’s why there’s never been a more crucial time for those in the biotechnology industry to consider seriously investing in professional language services, as the consequences of a mistranslation could be enormous. For example, mistranslating or omitting key information about drug side effects in a clinical trial could impair the validity of the participants’ informed consent. This could result in a damaged company reputation, serious legal issues or the compromised safety and wellbeing of the participants.
The biotechnology sector, a prominent domain within the life sciences industry, is subject to rigorous regulations to safeguard patient well-being. Implementing biotech regulatory translations for all essential documentation proves to be a valuable strategy to navigate these stringent laws and guidelines and seamlessly extend operations into diverse global markets. This ensures compliance with international safety standards, facilitates the expansion of biotech ventures into new markets while overcoming language barriers efficiently.
According to the Biotechnology Innovation Organisation (BIO), more biotech drug products, and vaccines are currently targeting several diseases, including various cancers, Alzheimer’s disease, diabetes, arthritis, and AIDS.
Biotechnology companies worldwide require the services of an experienced biotechnology translation company when translating important documents, such as research documentation for a partner in another country. Hire our biotech translators who use their vast industry knowledge and expertise to connect you with your global client base.
Biomedica Translations provides high-quality biotechnology industry translations in more than 100 languages, and our subject-matter experts are experienced in various life science translation fields, including biotechnology translation services, clinical trial translation services and biotech translation services. Our team of biotechnology translators regularly provide their biotechnology translations expertise to pharmaceutical companies and medical device manufacturers, ensuring that nothing is lost in translation.
